5395512026-04-012026-06-305395512026-06-305395512026-04-012026-06-30in-capmkt:OtherExpenses1Member5395512026-04-012026-06-30in-capmkt:OtherExpenses2Member5395512026-04-012026-06-30in-capmkt:ReportableSegments1Member5395512026-04-012026-06-30in-capmkt:ReportableSegments2Member5395512026-04-012026-06-30in-capmkt:ReportableSegments3Member5395512026-04-012026-06-30in-capmkt:ReportableSegments1Member5395512026-04-012026-06-30in-capmkt:ReportableSegments2Member5395512026-04-012026-06-30in-capmkt:ReportableSegments3Member5395512026-04-012026-06-30in-capmkt:ReportableSegments1Member5395512026-06-30in-capmkt:ReportableSegments1Member5395512026-04-012026-06-30in-capmkt:ReportableSegments2Member5395512026-06-30in-capmkt:ReportableSegments2Member5395512026-04-012026-06-30in-capmkt:ReportableSegments3Member5395512026-06-30in-capmkt:ReportableSegments3Member5395512026-04-012026-06-30in-capmkt:ReportableSegments1Member5395512026-06-30in-capmkt:ReportableSegments1Member5395512026-04-012026-06-30in-capmkt:ReportableSegments2Member5395512026-06-30in-capmkt:ReportableSegments2Member5395512026-04-012026-06-30in-capmkt:ReportableSegments3Member5395512026-06-30in-capmkt:ReportableSegments3Member5395512026-04-012026-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15395512026-04-012026-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss25395512026-04-012026-06-30ItemsThatWillBeReclassifiedToProfitAndLoss15395512026-04-012026-06-30ItemsThatWillBeReclassifiedToProfitAndLoss2iso4217:INRxbrli:pureiso4217:INRxbrli:shares539551NHNOTLISTEDINE410P01011Narayana Hrudayalaya Ltd.Main BoardEquity2026-04-012027-03-312026-07-312026-07-27INRMillionsQuarterlyFirst quarterMulti segment2026-07-3115:30:002026-07-3118:00:00Not applicable2026-04-012026-06-30UnauditedConsolidated268363400003547600002719110000005203060000-6024000072483800008680100001560810000974812000024568140000262296000002622960000557030000-25840000531190000-19070000207270000000002072700000-13225000019404500002071780000920000193953000092000020436100001010.210.20010.210.20.01240.02230.04The amounts of Rs. (19.07) disclosed under Point No. 10 represent our share of loss from equity-accounted investees. If these amounts are instead presented under Point No. 15 (being the appropriate tab for presentation in our internal financial statements), only the classification changes. The overall profit figure remains unchanged. <br /> <br /> In other words, this is merely a reclassification from Point No. 10 to Point No. 15 to ensure alignment with our internal financial statement presentation. There is no impact on the total profit as reported in the financials. <br /> <br /> <br /> The notes to the financial statements are attached as part of the Outcome of Board Meeting filing. Kindly refer to the same.Professional Fees to doctors3270100000Other expenses6478020000Medical and healthcare related services25403490000Unallocated other income354760000Others15635600002732181000013071000027191100000Medical and healthcare related services3741750000Unallocated other income354760000Others-624610000347190000086801000002603890000Medical and healthcare related services102443720000Unallocated other income21853690000Others34271700001277245800000127724580000Medical and healthcare related services25672350000Unallocated other income53096560000Others162000000080388910000080388910000Re-measurement gains/ (losses) on defined benefit plans-52540000Equity instruments through other comprehensive income, net-12310000-64850000-11790000Effective portion of gains/ (losses) in cash flow hedges-79630000Exchange differences in translating the financial statement of foreign operations440000-791900000-132250000